Major Players in Thailand Fluoxetine Market | Top Companies & Insights 2026

Thailand Fluoxetine Market Overview

According to 6Wresearch, the Thailand fluoxetine market is experiencing sustained growth as mental health awareness increases and clinical diagnosis rates for depression and obsessive-compulsive disorder (OCD) rise. Fluoxetine is commonly considered as a low-cost, first-line treatment in Thailand, with extensive integration into Universal Health Coverage (UHC) protocols.

Technological advancements in the market aims to improve patient adherence by developing a variety of dosage forms, such as high-purity capsules and oral solutions for pediatric or geriatric use.

Competitive Landscape

The competitive landscape of the Thailand fluoxetine market involves a strategic balance between state-mandated production and private-sector distribution. Companies compete primarily on reliability of supply, cost-efficiency for the public sector, and brand recognition within the retail pharmacy networks.

Below is a list of leading players operating in the Thailand Fluoxetine Market:

1. The Government Pharmaceutical Organization (GPO)

The state enterprise responsible for the mass production of generic fluoxetine to ensure affordability within the national public health framework.

2. Siam Bheasach Co., Ltd.

A dominant private manufacturer known for its high-fidelity generic psychiatric drugs that are a staple in retail and hospital pharmacies.

3. Continental-Pharm Co., Ltd.

A key domestic player producing various strengths of fluoxetine, focusing on clinical reliability and widespread distribution.

4. Thai Nakorn Patana Co., Ltd.

Utilizes its established brand heritage and vast logistics network to supply essential neuro-psychiatric medications across Thailand.

5. Berlin Pharmaceutical Industry Co., Ltd.

A pioneer in the Thai pharmaceutical industry, focusing on high-quality psychiatric formulations for chronic mental health management.

6. Biolab Co., Ltd.

Specializes in high-standard PIC/S GMP manufacturing and serves as a major partner for both local supply and regional export.

7. Eli Lilly and Company

The originator of the Prozac brand, Eli Lilly maintains a presence in the premium sector for clinicians who prefer the original innovator brand.

8. Siam Pharmaceutical Co., Ltd.

A long-standing pharmaceutical entity that supplies a broad range of essential generic capsules to the public procurement sector.

9. Millimed Co., Ltd.

A modern manufacturing firm recognized for meeting international production standards and expanding its reach into ASEAN markets.

10. Atlantic Laboratories Corporation

Manages a significant portfolio of neuro-psychiatric drugs, serving both the private pharmacy retail sector and hospital networks.

11. Vesco Pharmaceutical Co., Ltd.

Produces high-standard generic psychiatric medications, contributing to the diversity and stability of the local drug supply.

12. Polipharm Co., Ltd.

Focuses on the production of high-quality, locally affordable generic pharmaceuticals, including critical neuro-pharmacological treatments.